Epalrestat is a carboxylic acid derivative that functions as a reversible, noncompetitive aldose reductase inhibitor used to treat diabetic neuropathy, a common long-term complication of diabetes mellitus.… Read more













Epalrestat is a carboxylic acid derivative that functions as a reversible, noncompetitive aldose reductase inhibitor used to treat diabetic neuropathy, a common long-term complication of diabetes mellitus. This category provides a comprehensive selection of reference standards designed for rigorous pharmaceutical analysis, including the active pharmaceutical ingredient, its various stereoisomers, and process-related impurities. Laboratories utilize these high-quality materials for impurity profiling, method validation, and routine quality control to ensure the stability and safety of the drug product. Furthermore, the inclusion of stable isotope labelled compounds provides internal standards for sensitive analytical techniques such as mass spectrometry, allowing for accurate quantification in complex matrices. By maintaining access to this range of certified reference materials, researchers can perform precise analytical testing and adhere to regulatory standards throughout the development and manufacturing lifecycle of this therapeutic agent.